Towards interprofessional medication safety risk management: a qualitative interview study for physicians in primary and secondary care

Exposing Vulnerabilities in Counterfeit Prevention Systems Utilizing Physically Unclonable Surface Features

Evaluating and Optimizing Machine Learning Models to Predict Drug Side Effects

Recent Advances on Thermochromic Inks for Security Applications

Disproportionality and time-to-onset analyses of drug-induced weight gain using the Japanese Adverse Drug Event Report database

Improving Pharmacovigilance via Systematic GASS Screening and Interdisciplinary Collaboration in the Outpatient Setting

Real world based on FAERS database: To explore the mining and analysis of adverse pregnancy events related to drug exposure

Comparative Real-World Safety Profiles of Six Selective Serotonin Reuptake Inhibitors: A Global Pharmacovigilance Analysis

Pharmacovigilance assessment of adverse events following yellow fever vaccination: Disproportionality analysis of VAERS reports, 2015–2025

Assessment of Pharmacovigilance Practices in Primary Healthcare Facilities in Nasarawa State, Nigeria

Enhancing Medication Safety with LLMs

Safety of Herbal Medicine in the Postpartum Period: A Hospital-Based Single-Arm, Prospective Observational Study (SAFEHERE-PC)

Role of Metabolites in Drug-Drug Interactions

Placebo in controlled clinical trials

Engagement and Awareness in the Age of Memes

Spain’s Rise in Off-Label Doxycycline Use for Sexually Transmitted Infections

ISMP Announces New Medication Safety Best Practices

Spain’s Rise in Off-Label Doxycycline Use for Sexually Transmitted Infections

ISMP Announces New Medication Safety Best Practices

New Medication Safety Standards strengthens Australia's response to preventable medicines harm

Burnout, depression, and medication errors among family physicians

Why We Should Defend the Consumer Product Safety Commission

Medical Product Alert N°6/2025: Falsified SIMULECT (basiliximab) for injection

Postmarket Drug Safety−Related Actions Before and After the US Food and Drug Administration Amendments Act

A Single-Center Prospective Study on Adverse Drug Reactions Associated With Polypharmacy in Elderly Outpatients

A Survey of Knowledge, Attitude, and Practice of Reporting of Adverse Drug Reactions by Indian General Population

Artificial Intelligence-driven prediction of Drug–Herb Interactions: A critical need in India’s pluralistic health culture and Pharmacovigilance framework

Digital monitoring in the Ayush Pharmacovigilance for safer health care

A meta-contrastive learning approach for clinical drug-drug interaction extraction from biomedical literature

The promise of cardiomyocyte computational models for drug safety

Prescribed Drugs and Interpersonal Violence: A Case–Non-Case Study in the Spanish Pharmacovigilance Database

Large Language Models for Drug-Related Adverse Events in Oncology Pharmacy: Detection, Grading, and Actioning

Assessment of pharmacovigilance awareness and adverse drug reaction reporting among hospital pharmacists: A nationwide survey

Peligros de la desinformación relacionada con la cardiología en las redes sociales

Estudio del Hospital Clínico Universidad de Chile alerta por resistencia a fármacos contra el VIH

Commission presents new EU Drugs Strategy and Action Plan against drug trafficking to protect citizens and disrupt criminal networks

Antibiotic-induced adverse drug reactions: investigating the utility of routinely collected data

Detection and Management of Signals Associated with Adverse Drug Reactions from Atorvastatin and Rosuvastatin: An Observational Study

Comparative Safety Profiles of Spironolactone, Eplerenone, and Finerenone: A Pharmacovigilance Study Based on FAERS Data from 2004 to 2024

Selection of Local Journals for Medical Literature Monitoring in Poland for Pharmacovigilance. Standard of the Polish Society of Pharmacovigilance–replication study